The reaction between formaldehyde and the side-chain of tryptophan results in a methylol adduct. This methylol adduct formation also occurs during reductive methylation reactions. In the current study, we investigate the fragmentation pattern of peptides with N-terminal dimethylation and methylol adduction at the tryptophan side-chain. Once formed, the methylol group can easily undergo water loss to form an imine. The peptides with imine or methylol adduct on tryptophan exhibit similar MS/MS fragmentation patterns. We observed ions resulting from an intramolecular reaction between the dimethylamino group at the peptide N-terminus or the lysine side-chain and the imine group. This reaction reduces the imine to a methyl group. We also observed the loss of the imine adduct on tryptophan. This reaction is likely to occur through the reaction of an amino or hydroxyl group with the imine adduct followed by subsequent loss of methylenimine or formaldehyde. (J Am Soc Mass Spectrom 2006, 17, 859 -866) 
The reaction between formaldehyde and the side-chain of tryptophan results in a methylol adduct. This methylol adduct formation also occurs during reductive methylation reactions. In the current study, we investigate the fragmentation pattern of peptides with N-terminal dimethylation and methylol adduction at the tryptophan side-chain. Once formed, the methylol group can easily undergo water loss to form an imine. The peptides with imine or methylol adduct on tryptophan exhibit similar MS/MS fragmentation patterns. We observed ions resulting from an intramolecular reaction between the dimethylamino group at the peptide N-terminus or the lysine side-chain and the imine group. This reaction reduces the imine to a methyl group. We also observed the loss of the imine adduct on tryptophan. This reaction is likely to occur through the reaction of an amino or hydroxyl group with the imine adduct followed by subsequent loss of methylenimine or formaldehyde. (J Am Soc Mass Spectrom 2006, 17, 859 -866) © 2006 American Society for Mass Spectrometry F ormaldehyde is a commonly used cross-linking reagent for protein modification and immobilization [1, 2] . One application involves the use of formaldehyde for amino group modifications in proteins through reductive methylation [3] [4] [5] . Formaldehyde reacts with the amino group at the N-terminus or lysine side-chain to produce a methylol group, which can subsequently lose water to form an imine. The imine can then be reduced to a methyl group by reaction with sodium cyanoborohydride [5] . Although the methylol and the imine are formed by reversible reactions, the reduction of the imine to a methyl group is irreversible [5] .
The reductive methylation labeling method was recently shown to be useful in comparative proteomics [6 -8] and de novo sequencing [9, 10] . Peptides with N-terminal dimethylation display several interesting fragmentation patterns [6, 10] . The mechanisms for those fragmentation patterns have been proposed [10] .
Previously, a study by Metz et al. reported the neutral loss of water from ions with methylol adducted arginine, cysteine, or histidine in the MS/MS [11] . In an earlier study, we observed the neutral loss of formaldehyde in the MS/MS of peptides with methylol modified arginine [10] . This neutral loss ion is more abundant than the neutral loss of water or the native fragments. Peptides with imine adducted tryptophan exhibit distinct fragmentation patterns compared to peptides with imine adducted arginine. In the MS/MS of peptides with imine adducted tryptophan, the peaks resulting from the neutral loss of water are more abundant than the native fragments and the peaks resulting from the loss of formaldehyde. We also observed ion pairs with a 2 Da mass difference in the MS/MS spectra of (CH 3 ) 2 DFSAW(imine)Aamide and (CH 3 ) 2 DFSAW(methylol)Aamide. The identities of those peaks were not determined in the previous work [10] .
In the current paper, we continue our study of this interesting fragmentation. An intramolecular reaction between the dimethylamine and the imine was discovered and characterized using chemical modifications. We also expanded our study to include other peptides with imine at different positions in the peptide sequence and peptides with dimethyl modification at the lysine side-chain.
Materials and Methods

Materials
DFSAWAamide (Pev-kinin 2) was a generous gift from Professor Michael Nusbaum (School of Medicine, University of Pennsylvania). GASFYSWGamide (Leucokinin VIII), LVVYPW (Myelopeptide-2), WTVPTA (rat Necrofibrin), DLWKQ (Uremic Pentapeptide), and pyrKWAP (Bradykinin-potentiating pentapeptide, pyr represents the presence of pyroglutamate at the Nterminus) were purchased from American Peptide Company (Sunnyvale, CA). The peptides were prepared as stock solutions of 0.1 mg/ml. Formaldehyde (37% vol/vol), and formaldehyde-D 2 (25% vol/vol) were purchased from Sigma-Aldrich (St. Louis, MO) and used directly without further dilution. NaBH 3 CN was purchased from Sigma-Aldrich. A 5 M solution of NaBH 3 CN was freshly prepared for each use. Formaldehyde and sodium cyanoborohydride are very toxic by inhalation, in contact with skin or if swallowed, and may cause cancer and heritable genetic damage. Thus, special caution must be taken when handling these chemicals (Sigma-Aldrich Safety Statements 26-36/37/39-45 and 26-28-36/37/39-45-60-61).
Reductive Methylation Reaction
One microliter of peptide standard solution was mixed with 15 l of buffer (NaOAc/HOAc, 1 M/1 M, pH ϭ 4.8), followed by the addition and mixing of 1 l of formaldehyde (or 1.5 l of formaldehyde-D 2 ), and subsequent addition of 1 l NaBH 3 CN. The labeling reaction was allowed to proceed at room-temperature for 6 h. The solution was then stored at Ϫ20°C before LC-MS/MS analysis.
Methyl Esterification Reaction
Methylation of the peptide standards using acidified methanol was carried out as previously described [12] . Briefly, the peptide standard solution was first dried down in a Savant SC 110 SpeedVac concentrator (Thermo Electron Corporation, West Palm Beach, FL) followed by the addition of 200 l of the acidified methanol solution. The solution was left to react for 2 to 3 h. Then it was dried down and resuspended with 20 l of deionized water.
LC-ESI-QTOF-MS/MS
The LC-MS/MS analysis was performed using a Waters capillary LC system coupled to a QTOF Micro mass spectrometer (Waters Corporation, Milford, MA). Chromatographic separations were performed on a reverse phase Microsil packed capillary column (C18, 75 m i.d. ϫ 100 mm length, 3.5 m particle size, 100 Å pore size; Micro-Tech Scientific Inc., Vista, CA). The mobile phases used were: (A) deionized H 2 O w/ 5% acetonitrile and 0.1% formic acid; (B) acetonitrile w/ 5% deionized H 2 O and 0.1% formic acid; (C) deionized H 2 O w/ 0.1% formic acid. An aliquot of sample was injected and loaded onto the trap column (PepMap C18, 300 m column i.d. ϫ 1 mm length, 5 m particle size, 100 Å pore size; LC Packings, Sunnyvale, CA) for desalting using mobile phase C at a flow rate of 30 l/min for 3 min. The gradient for the analysis of the peptide standards was 1% B increments per minute starting from 5% B at 200 nl/min. The nanoflow electrospray ionization (ESI) source conditions were set as follows: capillary voltage 3800 V, sample cone voltage 40 V, extraction cone voltage 1 V, source temperature 120°C, cone gas 13 l/h. The collision energy during the MS scan was set at 5 eV. The information on MS/MS scan range and collision energy for each MS/MS scan is included in the corresponding figure caption.
Results and Discussion
The MS/MS of (CH 3 (Figure 1b ). The imine adducted indole ring is aromatic. Due to the stability of W( ϭ CH 2 ), the loss of water from peptides with a methylol adducted Trp during the MS and MS/MS scans is facile [10] . The methylol and imine modified forms exhibit similar fragmentation patterns for the same reason.
) 2 DFSAW(imine)Aamide and (CH 3 ) 2 DFSAW(methylol)Aamide
In Figure 1b (Figure 1c and d) . In the MS/MS of (CHD 2 ) 2 DFSAWAamide (Figure 2a ) and its imine modified form (Figure 2b and 
The presence of a 3 Da mass shift in the di-D 2 -methyl labeled form and a 2 Da mass shift in the methyl labeled forms indicates that a hydrogen atom from the Nterminal methyl group is transferred to the Trp imine. The imine was converted into a methyl group after the reaction. The ions with side-chain methyl modified Trp are marked by a double prime (Љ) in the later text.
Based on these experimental results, we propose the fragmentation pathways for the formation of those ion series described above (Schemes 1, 2 and 3) . In the following sections, we discuss these fragmentation pathways in detail.
The Formation of Ions with Imine or Methyl Modified Trp
As shown in Scheme 1a, the transfer of the hydrogen from the N-terminal methyl group to the imine ad-ducted Trp produces the methyl modified Trp. The precursor ions with imine adducted Trp are named ion A for the convenience of discussion. The ion with methyl modified Trp is named ion B. Due to the lack of a mobile proton, the subsequent fragmentation of ions A and B is charge remote [13] . The fragmentation of ion A produces y= ions (y 2 = to y 5 =, Scheme 1b, Pathway I). The y 1 ion cannot be produced because the charge (imine) is located on the N-terminal counterpart and The y= and the a/b-2 ions are the dominant ions in the MS/MS spectra. The less abundant yЉ (y=ϩ2) and a/b ions do not contain fixed positive charges; therefore, a mobile proton is required to form these ions. As shown in Scheme 2a, the carbonyl group of Asp 1 in ion B attacks the N-terminal imine to form a five-member ring and produces a mobile proton (ion C). The proton can be mobilized to other amide nitrogen and charge directed fragmentation produces b-2 or y= ϩ 2 (yЉ) ions, depending on where the charge is retained [14] . If the peptide bond is cleaved between Trp 5 and Ala 6 , b 5 Љ Ϫ 2 and y 1 ions are formed.
As shown in Scheme 2b (Pathway IV), the adjacent C-terminal carbonyl group attacks the imine, and the amide nitrogen donates a lone pair of electrons to form a double-bond with the amide carbon (ion D). The original amide hydrogen can then be mobilized to other locations to initiate charge directed fragmentation. The a/b ions (without Trp) or the y 1 /y= (y 2 = through y 5 =) ions can be formed depending on where the charge is retained.
The Formation of the Ions with Unmodified Trp
The loss of formaldehyde from the methylol adducted Trp to form unmodified Trp is expected because reaction between formaldehyde and amine is reversible [5] . However, the formation of an unmodified Trp residue from an imine adducted Trp is a different situation. This fragmentation requires the participation of other groups because the direct loss of a carbon atom from imine (W ϭ CH 2 ) or the loss of carbene from the methyl group (W Ϫ CH 3 ) is very unlikely. Several functional groups could participate in this reaction, including the ( ϭ CH 2 )Aamide ( loss of ammonia from the C-terminus, Figure S1 in the Supplementary Material section, which can be found in the electronic version of this article.) [15] , the 706.34 ϩ , b 5 o , and y o Ϫ NH 3 ions are not detected, which is consistent with the proposed fragmentation pathway. For peptides with a free C-terminus, the transfer of the C-terminal hydroxyl group to the imine followed by the loss of formaldehyde is expected.
Scheme 3b shows the proposed fragmentation pathway for the formation of unmodified Trp-containing fragment ions from the y= ions. The N-terminal amino group participates in this reaction and the y 1 /y o ions can be produced. Because the y 1 ion or other y o ions were not detected (Figure 1c and d) , this fragmentation pathway does not appear to be the major pathway for the formation of the ions with unmodified Trp from this particular peptide.
Similarly, there is no evidence supporting the participation of the hydroxyl group of Asp 1 or Ser 3 in elimination of the imine group. The hydroxyl group at the side-chain of Asp 1 may not participate in the reaction because (CH 3 ) 2 D(CH 3 )FSAW( ϭ CH 2 )Aamide with Asp 1 side-chain methylation also produces fragment ions with unmodified Trp (e.g., a 5 o and b 5 o , Figure  S2 ). There is no loss of formaldehyde from the y 4 = ion either (y 4 = Ϫ CH 2 O ϭ y 4 o Ϫ H 2 O). Thus, the hydroxyl group of Ser 3 is not involved in the reaction. It is noted that the y 4 o Ϫ NH 3 ion is detected, suggesting that the C-terminal amino group is a better leaving group than the hydroxyl group of Ser 3 or Asp 1 , which causes the transfer of the C-terminal amino group to the imine.
The loss of the imine group at the N-terminus of ion B is also observed. In the MS/MS spectrum of (CH 3 ) 2 DFSAW( ϭ CH 2 )Aamide (Figure 1d 
The Immonium Ion and Related Ions of Imine Modified Trp
In the MS/MS of (CH 3 ) 2 DFSAW( ϭ CH 2 )Aamide (Figure 1c ), the immonium ions of unmodified Trp (159 ϩ ), imine adducted Trp (171 ϩ , 199 ϩ ), and methyl adducted Trp (173 ϩ , 144 ϩ , 201 ϩ ) can be found. The proposed structures for those ions are shown in Scheme 4. The 187 ϩ ion has not been reported previously [16 -19] . In the MS/MS of the deuterium labeled form (Figure 2b) , the corresponding ions are W (159 ϩ ), W= (173 ϩ , 201 ϩ ), and WЉ (175 ϩ /176 ϩ , 146 ϩ /147 ϩ , 203 ϩ / 204 ϩ ).
These ions can be used as signature ions for the presence of the imine or methylol adduct of Trp.
The MS/MS of Other Peptides with the Imine Adduct of Trp
Several other peptides with Trp at different positions in the peptide sequence were also examined: (CH 3 ) 2 GASFYSW ( ϭ CH 2 )Gamide ( Figure S3 ), (CH 3 ) 2 LVVYPW( ϭ CH 2 ) ( Figure S4 ), and (CH 3 ) 2 W( ϭ CH 2 )TVPTA ( Figure S5 ). The MS/MS spectra of (CH 3 ) 2 GASFYSW( ϭ CH 2 )Gamide and (CH 3 ) 2 LVVYPW( ϭ CH 2 ) reveal the presence of the ion series described in the previous sections. The y 2 o ion in the MS/MS of (CH 3 ) 2 LVVYPW( ϭ CH 2 ) is likely produced from the y= ion as shown in Scheme 3b. In the MS/MS of (CH 3 ) 2 W( ϭ CH 2 )TVPTA ( Figure S5) , the presence of the immonium ion and related ion of WЉ (144.11 ϩ , 201.17 ϩ ) suggests that intramolecular reaction between the N-terminal dimethylamino group and the imine of Trp 1 occurs. The 201.17 ϩ ion corresponds to the 173 ϩ ion shown in Scheme 4 with N-terminal dimethyl modification. Because the reaction occurs within the same residue, the a/b-2 and yЉ ions cannot be produced.
The peptides pyrK(CH 3 ) 2 W(CH 2 OH)AP and pyrK (CHD 2 ) 2 W(CD 2 OH)AP were used to investigate whether the dimethylamino group at the Lys side-chain can react with the imine (Figure S6 ). The presence of the b 2 -2/a 2 -2 and WЉ ions indicate that the reaction does occur. Another signature ion of this reaction is the 155.16 ϩ ion, which is seen in Figure  S6A and corresponds to the loss of 2 Da from the 157 ϩ ion (the immonium ion of Lys(CH 3 ) 2 ϩ CO). In the deuterium labeled forms, the 158.17 ϩ and 159.17 ϩ ions correspond to the losses of 3 Da and 2 Da from the 161 ϩ (the immonium ion of Lys(CHD 2 ) 2 ϩ CO) ion.
The MS/MS fragmentation of (CH 3 ) 2 DLW(CH 2 OH) QK(CH 3 ) 2 was also studied ( Figure S7 ). The spectra reveal the presence of the ions resulting from the reaction between the imine and the dimethylamino groups at both the N-terminus and the side-chain of lysine.
Conclusion
In the current study, we report a novel intramolecular reduction-oxidation reaction during the gas-phase fragmentation of peptides with dimethylation modification and imine or methylol adducted tryptophan. The dimethylamine at the N-terminus and the lysine sidechain of a peptide can provide the hydrogen atoms needed to reduce the imine to a methyl group. This reaction produces two groups of signature ions: ions with a dimethyl group minus 2 Da and ions with an imine adducted tryptophan plus 2 Da. The loss of imine or methylol adduct is also observed. The MS/MS also reveals the presence of an array of immonium and related ions of imine adducted tryptophan, methyl modified tryptophan, and unmodified tryptophan. This study provides a viable strategy to determine the presence and location of Trp residues in a peptide sequence by reductive methylation.
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